Joseph Araujo
Founder at MINDSET PHARMA INC.
Net worth: 66 600 $ as of 2023-10-30
Joseph Araujo active positions
Companies | Position | Start | End |
---|---|---|---|
MINDSET PHARMA INC. | Director/Board Member | 2019-10-06 | - |
Chief Tech/Sci/R&D Officer | 2019-10-06 | - | |
Founder | 2019-10-06 | - | |
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Chief Executive Officer | 2022-02-28 | - |
Founder | 2001-12-31 | - | |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Director/Board Member | - | - |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Director/Board Member | 2021-09-15 | - |
Career history of Joseph Araujo
Former positions of Joseph Araujo
Companies | Position | Start | End |
---|---|---|---|
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Chief Executive Officer | 2009-12-31 | 2023-02-28 |
President | 2009-12-31 | 2023-02-28 | |
KARYOPHARM THERAPEUTICS INC. | Director/Board Member | 2008-12-21 | 2010-08-31 |
Director of Finance/CFO | 2008-12-21 | 2010-08-31 | |
Founder | 2008-12-21 | 2010-08-31 |
Training of Joseph Araujo
University of Toronto | Undergraduate Degree |
Statistics
International
Canada | 6 |
United States | 2 |
United Kingdom | 2 |
Operational
Director/Board Member | 4 |
Founder | 3 |
Chief Executive Officer | 2 |
Sectoral
Health Technology | 4 |
Commercial Services | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
KARYOPHARM THERAPEUTICS INC. | Health Technology |
MINDSET PHARMA INC. | Health Technology |
Private companies | 4 |
---|---|
CanCog Technologies, Inc.
CanCog Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services CanCog Technologies, Inc. operates as a contract research organization providing non-invasive research and development services in the companion animal market. The firm's services include food intake, cognitive assessment, activity and movement, imaging and special technologies. The company was founded by Norton William Milgram and David R. Stevens in 2002 and is headquartered in Toronto, Canada. | Commercial Services |
InterVivo Solutions, Inc.
InterVivo Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services InterVivo Solutions, Inc. offers high-quality, translational drug discovery services to accelerate drug discovery programs to the clinic. The Canadian company provides a carefully selected array of neuroscience models and experiments to help propel new drugs forward through the development track. The private company's designed pharmacokinetics studies provide reliable data ensuring faster screening, selection, and development of lead candidates. The company has expertise in neurological disease models and laboratory testing capabilities to support emerging research. The company welcomes inquiries for novel approaches for model and bioanalytical development. Additionally, Transpharmation, a preclinical neuroscience CRO, relays a number of natural models of disease via the largest world-class canine colony in the industry. InterVivo Solutions can assist in discovering how they can help. | Commercial Services |
Vivocore, Inc.
Vivocore, Inc. Miscellaneous Commercial ServicesCommercial Services Vivocore, Inc. is a non-invasive research and Canadian development company. | Commercial Services |
Transpharmation Ltd.
Transpharmation Ltd. BiotechnologyHealth Technology Part of Vivocore, Inc., Transpharmation Ltd. is a contract research organization. The company is based in London, UK. The British company was founded in 2010 by Neil Upton, Mark Steven Duxon. Mark Steven Duxon has been the CEO since 2010. Transpharmation was acquired by Vivocore, Inc. on February 07, 2022. | Health Technology |
- Stock Market
- Insiders
- Joseph Araujo
- Experience